Effect of a Nutraceutical Combination on Oxidative Stress Biomarkers in Healthy Subjects and Patients with Alzheimer’s Disease
Nutrients · 2026
DOI: 10.3390/nu18050789 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2026. Verfasst von Rafał Jastrząb und 15 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development Center, Olimp Laboratories Sp. z o.o., 39-200 Dębica, Poland. Hauptthemen laut MEDLINE: Oxidative Stress, Alzheimer Disease, Dietary Supplements. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Centre for Research and Development, National Centre for Research and Development.
Themen: Demenz
Abstract (Originalsprache)
Background/Objectives: Advanced glycation end products (AGEs) and oxidative stress increase with aging and are implicated in Alzheimer’s disease (AD). We developed an anti-glycation blend using LC-MS-based screening and assessed its effects on oxidative and glycation-related biomarkers in humans.
Methods
Twelve candidate compounds were screened in a BSA–glucose model using LC-MS peptide mapping to quantify lysine glycation and rank inhibitory activity. The top candidates were combined into a three-compound blend (quercetin, rutin, genistein). In a randomized, double-blind, placebo-controlled 3-month trial, older healthy adults (n = 30) and individuals with AD (n = 30) received anti-AGE blend (n = 15 in older group and n = 15 in AD group) or placebo (n = 15 in older group and n = 15 in AD group). Serum malondialdehyde and urinary Nε-(carboxymethyl)lysine were measured pre–post intervention. Pre/post and between-arm comparisons within each population were performed using REML ANOVA with Tukey post hoc tests. Serum MDA (malondialdehyde) and urinary CML (Nε-(carboxymethyl)lysine) were prespecified biomarker outcomes and are reported here as co-primary biomarker endpoints. No formal a priori sample size calculation was performed; the study size was feasibility-based.
Results
LC-MS screening identified genistein, quercetin, and rutin as the most consistent inhibitors of glucose-driven BSA glycation. In older healthy adults, serum MDA decreased after anti-AGE supplementation (p < 0.001) and differed from the placebo (p < 0.01), while no change was observed within the placebo group (ns). In the AD cohort, MDA did not change significantly from baseline within either arm (ns), but post-intervention MDA was lower in anti-AGE than in the placebo (p < 0.05). Urinary CML was unchanged in older healthy adults (ns in both arms), whereas in AD, it decreased after anti-AGE supplementation (p < 0.01) and differed from the placebo (p < 0.05).
Conclusions
A screening-guided anti-glycation blend supplementation was associated with changes in selected biomarkers in humans: MDA decreased across cohorts, while CML decreased selectively in AD. Larger trials with extended biomarker panels and LC–MS/MS confirmation are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research and Development Center, Olimp Laboratories Sp. z o.o., 39-200 Dębica, Poland.
- Laboratory of Molecular Biology, Institute of Physiotherapy and Health Sciences, Academy of Physical Education, 40-065 Katowice, Poland.
- Neurorehabilitation Ward, Silesian Voivodship Hospital No 5, 41-200 Sosnowiec, Poland.
- Department of Neurology, School of Health Sciences, Medical University of Silesia in Katowice, 40-007 Katowice, Poland.
- Department of Neurology, Faculty of Health Sciences in Katowice, Medical University of Silesia, 40-007 Katowice, Poland.
- Doctoral School of Medical and Health Sciences, Silesian Medical University, 40-007 Katowice, Poland.
ORCID-Profile: Rafał Jastrząb, Agnieszka Gorzkowska, Marta Nowacka-Chmielewska, Konstancja Grabowska, Natalia Pondel, Gabriela Początek, Jennifer Mytych
Förderung
- The National Centre for Research and Development
- National Centre for Research and Development
Zitieren
APA
Jastrząb, R., Małecki, A., Kmiecik-Małecka, E., Gorzkowska, A., Kubas, K., Widłak-Kargul, J., Wolman, D., Matkiewicz, K., Nowacka-Chmielewska, M., Liśkiewicz, D., Grabowska, K., Grabowski, M., Pondel, N., Początek, G., Kłodowska, G., & Mytych, J. (2026). Effect of a Nutraceutical Combination on Oxidative Stress Biomarkers in Healthy Subjects and Patients with Alzheimer’s Disease. Nutrients. https://doi.org/10.3390/nu18050789
Vancouver
Jastrząb R, Małecki A, Kmiecik-Małecka E, Gorzkowska A, Kubas K, Widłak-Kargul J, et al. Effect of a Nutraceutical Combination on Oxidative Stress Biomarkers in Healthy Subjects and Patients with Alzheimer’s Disease. Nutrients. 2026. doi:10.3390/nu18050789
BibTeX
@article{Jastrzb2026,
author = {Jastrząb, Rafał and Małecki, Andrzej and Kmiecik-Małecka, Elżbieta and Gorzkowska, Agnieszka and Kubas, Kamil and Widłak-Kargul, Justyna and Wolman, Damian and Matkiewicz, Katarzyna and Nowacka-Chmielewska, Marta and Liśkiewicz, Daniela and Grabowska, Konstancja and Grabowski, Mateusz and Pondel, Natalia and Początek, Gabriela and Kłodowska, Gabriela and Mytych, Jennifer},
title = {Effect of a Nutraceutical Combination on Oxidative Stress Biomarkers in Healthy Subjects and Patients with Alzheimer’s Disease},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18050789}
}
EUVIMED